Ascentage Pharma Grp Intl (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascentage Pharma Group International - ADR: Is Infosys Ltd. worth buying?
Item: Ascentage Pharma Group International - ADR
Rating: 1.14966675
Author: Trendlyne DVM scores

about

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing ther...

26.36 -1.04 (-3.80%)

45.59% Fall from 52W High

1,928

XNAS Volume

XNAS 20 Apr, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Ascentage Pharma Grp Intl (ADR) is on 23 Apr 2026 for the purpose of Ascentage Pharma Group International Annual Report for 2025 See details

Not Eligible

Expensive Valuation

0.2 / 100

Technically Neutral

45.8 / 100

1Yr Price target upside is 86%

7 analysts

Ascentage Pharma Grp Intl (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..